MedMira's Biosensor Division to Collaborate with National Research Council on Breast Cancer Research
MedMira Inc. announced that it has entered into a collaborative agreement with the National Research Council of Canada (NRC), through its biosensor division, Maple BioSciences. The agreement will allow NRC to work with Maple BioSciences on the discovery and validation of breast cancer biomarkers. The project will commence when the final agreement and details are completed in early 2007.
The NRC/Maple Biosciences partnership shall bring together research and the mapleTWO technology resulting in advanced diagnostics and additional accuracy in the classification of the various breast cancer development stages. mapleTWO, based on the SKN (scanning Kelvin nanoprobe) technology, is a sensitive tool for detecting the biomolecular interactions that form the heart of clinical diagnostics.
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Last viewed contents
Domainex Collaborates with Sigma-Aldrich to Advance the Study of Epigenetic Proteins Involved in Cancer and Stem Cell Biology
PharmaStem Patents Confirmed after Reexamination by Patent Office
